HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

Nordic Microbial Transglutaminase Market Size & Outlook, 2025-2033


Nordic Microbial Transglutaminase Market Insights

  • Reed Intelligence analysis indicates that the Nordic Microbial Transglutaminase Market size, valued at USD 1.51 Million in 2024, is expected to expand to USD 3.58 Million by 2033.
  • The Nordic market is forecasted to expand at a CAGR of 10.13% spanning 2026–2033.
  • Streptomyces Mobaraense held the leading position among By Source segments in 2024, based on market size.
  • Streptoverticillium Hygroscopicus is projected to post the fastest growth rate, sustaining its position as the most attractive By Source segment during the forecast horizon.

Other Key Findings


  • Nordic contributed 1.11% to the global Microbial Transglutaminase Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Microbial Transglutaminase Market.
  • In Europe, Germany is projected to capture the leading share of market size by 2033.
  • Among Europe markets, Nordic is expected to post the fastest growth, reaching USD 3.57 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 1.51 Million
Market Size In 2033 USD 3.58 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 10.13% (2025-2033)
Segmnetation Covered
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports